Sat.Dec 26, 2020 - Fri.Jan 01, 2021

article thumbnail

Vulnerable should all get COVID-19 shot before summer, says NHS chief

pharmaphorum

NHS England’s chief executive Sir Simon Stevens has said that all vulnerable people over the age of 50 will be offered a COVID-19 vaccine by “late spring” in a message to healthcare workers. The prediction comes after the NHS announced on Christmas Eve that more than half a million people had received the Pfizer/BioNTech shot approved in early December, but will depend on additional vaccine supplies coming “on stream”, according to Stevens.

Vaccines 101
article thumbnail

[WEBINAR] Video, Voice, and Virtual: Applying New Digital Technology to Enhance Customer Experience

Pharma Marketing Network

2020 was a year defined by unexpected challenges – and related opportunity – for pharmaceutical marketers. The COVID-19 pandemic pushed the industry to experiment with new media, emerging technologies and innovative platforms to keep physicians, providers and patients informed, engaged and empowered. As telehealth appointments replaced office visits, webinars replaced in-person conferences and digital communication replaced reps in the field, what have we learned about how to create connec

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

New patent for Kala Pharms drug INVELTYS

Drug Patent Watch

Annual Drug Patent Expirations for INVELTYS Inveltys is a drug marketed by Kala Pharms Inc and is included in one NDA. There are eight patents protecting this drug. INVELTYS drug…. The post New patent for Kala Pharms drug INVELTYS appeared first on DrugPatentWatch - Make Better Decisions.

93
article thumbnail

For Covid-19 Vaccines, Some Are Too Rich — and Too Poor

NY Times

Global inequality is shaping which countries get vaccines first. In South Africa, people’s best chance for vaccines anytime soon is to join an experimental trial.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Episode 570: Euglycemic Diabetic Ketoacidosis After Stopping Canagliflozin

Pharmacy Joe

In this episode, I’ll discuss the possibility of euglycemic DKA occurring after stopping canagliflozin. Episode 570: Euglycemic Diabetic Ketoacidosis After Stopping Canagliflozin Subscribe on iTunes , Android , or Stitcher Shout-out to “Pharmacy Ashley” for inspiring this episode! Sodium-glucose cotransporter-2 (SGLT2) inhibitors are known to carry an increased risk of diabetic ketoacidosis (DKA) which may occur with lower than usual glucose levels, even with euglycemia.

article thumbnail

2021 BCMTMS Exam Changes and Why It Will Be Harder

Med Ed 101

It is well known that we create study materials for several board exams. I’m often one of the first to know when changes happen because people ask me how it should impact their preparations! The 2021 BCMTMS Exam changes are some of the most expansive that I have seen to any board exam. You must […]. The post 2021 BCMTMS Exam Changes and Why It Will Be Harder appeared first on Med Ed 101.

40

More Trending

article thumbnail

Don’t Worry Too Much About Covid Vaccine Allergic Reactions

NY Times

We should expect some people to experience side effects. The shot is still safer than the disease.

article thumbnail

AZ COVID-19 vaccine cleared in UK, dosing to start next week

pharmaphorum

The UK has approved AstraZeneca and Oxford University’s COVID-19 vaccine AZD1222 in another significant step forward in the fight against the pandemic, with first doses due to be administered on Monday. The UK government has already ordered 100 million doses of the adenovirus-based shot, enough to vaccinate 50 million people, adding to the 40 million dose order of the Pfizer/BioNTech shot – now known as Comirnaty – that was approved earlier this month.

article thumbnail

Which Drugs to Avoid in Kids? My Top 5

Med Ed 101

While I primarily practice in geriatrics, I’ve also spent some time in community pharmacy and of course, get asked questions about medications in kids from time to time. In addition to getting asked questions in clinical practice, you’ll likely be tested on some of these pearls when taking board exams and pharmacology classes. Here are […].

article thumbnail

New patent for Nevakar drug EPHEDRINE SULFATE

Drug Patent Watch

Annual Drug Patent Expirations for EPHEDRINE+SULFATE Ephedrine Sulfate is a drug marketed by Akorn, Amneal, Dr Reddys Labs Ltd, Fresenius Kabi Usa, Nevakar, and Sandoz Inc and, and is included…. The post New patent for Nevakar drug EPHEDRINE SULFATE appeared first on DrugPatentWatch - Make Better Decisions.

52
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Don’t Let the Pandemic Stop Your Shots

NY Times

Even as older adults await the coronavirus vaccine, many are skipping the standard ones. That’s not wise, health experts say.

article thumbnail

UK parliament backs EU trade deal, as industry sifts through detail

pharmaphorum

The post-Brexit trade deal agreed on Christmas Eve has been overwhelmingly backed by the UK parliament, providing some degree of stability – but also plenty of disruption – for the coming months and years. The UK is leaving the EU’s single market and customs union, but the deal means tariffs on goods won’t be imposed when the transition period ends at 23:00 GMT tonight.

article thumbnail

Episode 569: Evidence for gastrointestinal cation exchangers other than sodium polystyrene sulfate in acute hyperkalemia

Pharmacy Joe

In this episode, I’ll discuss the evidence for gastrointestinal cation exchangers other than sodium polystyrene sulfate in acute hyperkalemia. Episode 569: Evidence for gastrointestinal cation exchangers other than sodium polystyrene sulfate in acute hyperkalemia Subscribe on iTunes , Android , or Stitcher In the treatment of acute hyperkalemia, IV calcium provides immediate cardioprotection and allows time for insulin to move potassium into the intracellular space and away from the heart.

article thumbnail

New patent expiration for Bristol Myers drug SPRYCEL

Drug Patent Watch

Annual Drug Patent Expirations for SPRYCEL Sprycel is a drug marketed by Bristol Myers Squibb and is included in one NDA. It is available from one supplier. There are five…. The post New patent expiration for Bristol Myers drug SPRYCEL appeared first on DrugPatentWatch - Make Better Decisions.

52
article thumbnail

The Risks of Using Steroids for Respiratory Infections

NY Times

Doctors often prescribe them for sore throats and the common cold, even though evidence of benefit is sorely lacking.

56
article thumbnail

Drug Patent Expirations for the Week of December 27, 2020

Drug Patent Watch

SPRYCEL (dasatinib) Bristol myers squibb Patent: 6,596,746 Expiration: Dec 28, 2020 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com…. The post Drug Patent Expirations for the Week of December 27, 2020 appeared first on DrugPatentWatch - Make Better Decisions.

40
article thumbnail

Which pharmaceutical companies have the most drug patents in Slovenia?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Slovenia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Slovenia? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Which pharmaceutical companies have the most drug patents in Spain?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Spain. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Spain? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Which pharmaceutical companies have the most SPCs in Estonia?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Estonia. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…. The post Which pharmaceutical companies have the most SPCs in Estonia? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Which pharmaceutical companies have the most gel dosed drugs?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most gel dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most gel dosed drugs…. The post Which pharmaceutical companies have the most gel dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Which pharmaceutical drugs have the most drug patents in Croatia?

Drug Patent Watch

This chart shows the drugs with the most patents in Croatia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Croatia? appeared first on DrugPatentWatch - Make Better Decisions.

52
article thumbnail

Which pharmaceutical companies have the most drug patents in Denmark?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Denmark. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Denmark? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Which pharmaceutical companies have the most drug patents in Israel?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Israel. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Israel? appeared first on DrugPatentWatch - Make Better Decisions.